Bora’s ESG vision

Our Vision

To realize our sustainability vision, fulfill corporate social responsibility and strengthen governance, Bora Pharmaceuticals established the Sustainability Committee in 2022. The committee focuses on 4 strategic pillars rooted in our core pharmaceutical business and aligned with the United Nations Sustainable Development Goals (SDGs). Through this framework, we actively promote sustainability in healthcare, advancing economic growth, social progress, and environmental protection while enhancing our competitiveness and expanding our positive impact as a pharmaceutical company.

Sustainability Objectives

Bora Pharmaceuticals actively commits to achieving sustainability goals. The Sustainability Development Executive Office collaborates with various working groups to discuss and establish short-, medium-, and long-term sustainability objectives. These goals were discussed with the Sustainability Development Committee and the Board of Directors on November 13, 2024.

	Short Term (2024-2025)	Mid Term (2026-2028)	Long Term (2029-2033)
E	Build EcoVadis compliant strategies and detailed roadmap to ensure Bora Group meets audit requirements of major global pharma clients Canada site evaluate and model SBTi-aligned emissions reduction pathways Commit to a net-zero emissions goal; conduct annual gap analysis and rollout energy saving audits of and carbon-reduction plans group-wide Complete GHG inventory and third-party assurance on group-consolidated basis	Obtain ISO 50001 certification for the parent company and facilities with high carbon intensity Obtain ISO 14001 certification and prepare for group-wide SBTi roadmap and carbon reduction trajectory	Set group-wide supplier carbon reduction or chemical emission targets and assist our suppliers to achieve adherent actions Achieve group-wide SBTi goals Promote the adoption of green process technologies
S	Conduct employee engagement surveys Implement human rights due diligence exercise across operations Devise community engagement initiatives aligned with Bora’s core pharmaceutical values and prepare for roll-out plans Develop responsible marketing policies as Upsher Smith’s specialty pharma business expand	Establish talent development and/or management trainee programs for key positions Create onboarding and corporate behavior SOPs for newly acquired facilities (Corporate Behavior & Governance)	Conduct group-wide sustainability and human rights risk assessments
G	Continue to refine corporate governance executions Establish a comprehensive whistleblower and grievance mechanism Create standardized and internal audit integral procedure for compiling and verifying Sustainability Report	Build group-wide risk management mechanisms Establish supplier sustainability audits and risk assessment schemes Adopt third-party cybersecurity risk assessment platforms	Integrate ESG performance into supplier selection criteria Adopt ISO 27001 (Information Security Management System)

Our Vision

Sustainability Objectives

Bora

Contact

Address

Quick Links